Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Relay Therapeutics, Inc. has filed 494 SEC EDGAR filings since 22 May 2020

SEC filing history

Showing 376-400 of 494 matching filings.

Per page
25
Current page
16
4

FORM 4 SUBMISSION

Filing date
16 Nov 2021
Reporting date
15 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Oct 2021
Reporting date
15 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39385

8-K FOR OCTOBER 12, 2021 FOLLOW-ON FINANCING

Filing date
14 Oct 2021
Reporting date
11 Oct 2021
Next action
Verify source filing
424B5 File 333-258768

424B5

Filing date
13 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-258768

424B5

Filing date
12 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Sep 2021
Reporting date
27 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Sep 2021
Reporting date
27 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Sep 2021
Reporting date
27 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Sep 2021
Reporting date
13 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Sep 2021
Reporting date
13 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B7 File 333-258768

424B7

Filing date
25 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B7 File 333-258768

424B7

Filing date
13 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3ASR File 333-258768

S-3ASR

Filing date
12 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39385

8-K

Filing date
12 Aug 2021
Reporting date
12 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92097

SC 13G/A filing

Filing date
12 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Jun 2021
Reporting date
28 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Jun 2021
Reporting date
28 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Jun 2021
Reporting date
28 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Jun 2021
Reporting date
16 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Jun 2021
Reporting date
07 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Jun 2021
Reporting date
07 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .